Several different segments of the gp41 N-heptad repeat coiled coil have been constructed using N-terminal bipyridyl modification of composite peptides and inducing trimerization by adding ferrous ions. These metallopeptides act as receptors in fluorescence-binding assays with apposing fluorescently labeled C-peptide probes. The Fe II coordination complex quenches C-peptide fluorescence upon binding, and reversal of quenching by a small molecule inhibitor can be used to obtain the inhibitor-binding constant. A total of 10 peptide pairs targeting 25-46 residue segments of the coiled coil were constructed, with C-peptide probes of different lengths and binding affinities. The result is a suite of assays for exploring binding in the mM to nM range to any desired region of the coiled coil, including the hydrophobic pocket (HP), extended regions on either side of the pocket, or a region associated with T20 resistance mutations. These assays are high-throughput ready, and could be used to discover novel compounds binding along various regions of the gp41 coiled coil groove. They were used to evaluate a sub-lM low molecular weight fusion inhibitor, resulting in the finding that the molecule bound specifically to the HP and attained its potency from a low off-rate.
INTRODUCTION
E ntry inhibitors are a relatively new class of approved human immunodeficiency virus type 1 (HIV-1) drugs, and have promising properties for combating resistance to current treatments and for prophylaxis.
1,2 They can act in both immune cell protection and disease prevention by targeting the steps of the viral life cycle that occur before infection of host cells. Fusion inhibitors are a class of entry inhibitors that act on the HIV transmembrane protein gp41, which is universally required by all strains for initial infection or cell-to-cell transmission. [3] [4] [5] A large conformational change occurs in gp41 during fusion, involving exposure of a homotrimeric N-heptad repeat (NHR) coiled coil and subsequent folding of antiparallel C-heptad repeat (CHR) helices down the grooves of the coiled coil, to form a trimer of hairpins, a prerequisite for effective fusion pore formation. 2 The gp41 coiled coil has been considered an important target for fusion inhibitors, based on peptides studies, which show that CHR peptides are highly effective fusion inhibitors. [6] [7] [8] These include T20, currently the only AU2 FDA-approved fusion inhibitor. 9 Small molecule fusion inhibitors have been sought for many years, but with limited success, having only mM potency against fusion. 10, 11 They have chiefly targeted a known hydrophobic pocket (HP) on the coiled coil. However, in many cases, there is little experimental evidence confirming the exact binding site and no way to test inhibitors against different sites along the coil. Finding two inhibitors that bind in adjacent sites could enable a fragment-based drug design approach, in which a linker connecting two adjacentbinding fragments can have a multiplicative effect on their binding affinity. 12 In previous work, we have demonstrated the use of metal-bipyridyl coordination to stabilize a segment of the gp41 coiled coil representing the HP, 13 as well as an extended receptor targeting adjacent sites and high-affinity interactions. 14, 15 This study expands on the analysis of inhibitors detected with these assays, and introduces a new assay that focuses on the N-terminal end of the coiled coil, a site prone to development of resistance mutations in viruses exposed to T20. 16 C-peptide probes have been designed for fluorescence intensity assays that interrogate the NHR subsections. Adjusting C-peptide length tuned both assay selectivity and the range of detectable affinities. Small molecule inhibitors could easily be detected by competitive inhibition, as we have shown previously.
Comparison of the results with the known biological activity of peptide segments of the CHR 17 and small molecules 18 confirmed the relevance of these biochemical screening assays for detection of fusion inhibitors. The ease and rapidity of the assays lends them to implementation in a high volume format. Utilization of the assays could result in identification of novel fragments or small molecules binding at specific subsites, with the possibility of linking them to generate high-affinity nonpeptide inhibitors. This concept has been applied for the derivation of C-peptide inhibitors of HIV-1 fusion containing multifunctional domains.
2,17

MATERIALS AND METHODS
Materials
Peptides were prepared by solid-phase synthesis (Biosynthesis, Inc.). Small molecules were prepared according to previously published procedures.
18 Fluorescein (FL) and Lucifer yellow (LY)
were purchased from Molecular Probes (Invitrogen) as iodoacetamides and covalently attached through standard cysteine disulfide chemistry according to the manufacturer's instructions. Labeled peptides were purified by AU2 HPLC using acetonitrile: H 2 O with 0.05% TFA AU2 .
Circular Dichroism Experiments
Circular dichroism (CD) studies were performed on a DSM20 CD spectrophotometer from On-Line Instruments Systems, Inc., using 20 mM solutions of peptides in a 15 mM Tris-acetate buffer, pH 7.0, at 25°C.
Fluorescence Intensity Measurements
Fluorescence intensity was measured in 384-well low-volume plates (Greiner Bio-one) on a Spectramax M5 plate reader (Molecular Devices). Env# concentration was determined in 6 M Gdn.HCl from the absorbance at 291 nm, using the extinction coefficients of bipyridine (e 291 = 12,000) plus the calculated contribution of any Trp and Tyr residues in the peptide sequence (www.expasy.org). FL-labeled peptide concentration was determined using e 495 = 93,000 M -1 cm -1 in 6 M Gdn.HCl at pH 9; LY-labeled peptide concentration was determined using e 425 = 10,800 M Tables 1 and   T2 2.
RESULTS AND DISCUSSION
Peptide Design
The array of overlapping segments used to scan the full-length coiled coil is shown in F1 Figure 1 . NHR peptide env2.0 contained the residues 565 LLQLTVWGIKQLQARIL 581 of the HP, as previously described, 13 and env3.0 14 and env4.0 were extended to include a region either C-terminal or N-terminal to the pocket, respectively. Env5.0 and env5.1 extended the N-terminal region even further, 15 and env6.0 contained just the N-terminal end of the coiled coil, without the HP. This region binds to the N-terminal two-thirds of T20. The env# peptides were modified with an N-terminal 5-carboxybipyridine (bpy) group and a linker sequence GQAV. Three bidentate bpy groups formed an octahedral complex with transition metal ions, stabilizing the trimeric form of the env# receptors. Figure 1 also depicts CHR peptides that were synthesized, aligned antiparallel to the NHR peptides, and labeled according to the number of residues and the cognate receptor. C18-e2.0 covered the HP and Nterminal adjacent region. C28-e5.1 and C21-e6.0 mimicked portions of T20 and did not contain HP-binding residues. C32-e5.0 and C39-e5.1 spanned close to the full length CHR. A fluorescent marker, LY or FL, was attached to each CHR peptide probe through a C-terminal cysteine, so that NHR-CHR binding could be followed by fluorescence quenching. The sensitivity of this experiment depended on the alignment of the fluorophore and metal complex, and C-peptides were designed with the fluorophore <18 Å from the metal. It was found that C-peptides designed for the receptors env5.1 and env6.0 were also quenched by env5.0, increasing the versatility of assay pairing. Sequences of the peptides are indicated in T3   Table 3 . The wild-type (HXB2) sequence was used for all NHR peptides, to maintain receptor integrity for inhibitor detection, but C-peptides contained several helix-stabilizing modifications on the solvent-exposed face, based on studies demonstrating their effect on enhancing affinity. 8, 19, 20 Several C-peptide sequence variations were tested, with the sequences shown providing a good combination of high helicity and enhanced solubility.
NHR Trimer Formation
Metal binding to bipyridylated NHR peptides (env#) generally resulted in stabilization of the coiled coil, evidenced by an increase in helical content to 50% or higher in CD spectra and a 208 nm:222 nM peak intensity ratio of 1.0, which indicated a-helix bundle formation. 21 An exception was the peptide env4.0, which did not give a well-structured helical coiled coil upon metal binding and subsequently performed poorly in fluorescence experiments. An apparent helical content >100% was observed for the peptide env5.1 both in the absence and presence of Fe 2 + . This was an indication of aggregation that was not ameliorated by metal binding, demonstrating a size limit of the self-assembly process in generating discreet trimers above a certain concentration. The CD results were confirmed by fluorescence studies (see below). The receptor Fe(env6.0) 3 defined the region of gp41 at the base of the coiled coil, immediately adjacent to the fusion peptide proximal region that interacts with lipid membrane. A recent crystal structure of an extended segment of the gp41 ectodomain 22 revealed a loss of helical periodicity in the N-terminal region that is included in Fe(env6.0) 3 ( Fig. 1 ). This did not appear to affect the formation of a well-formed trimer, although it may explain the lower helical content observed compared to other well-formed receptors. Fe(env6.0) 3 is the segment of the gp41 coiled coil to which T20 binds, including the residues 544 LLSGIVQQQ 552 that are known to make important energetic interactions with T20. 16 Mutations within these residues are strongly associated with resistance to T20, [23] [24] [25] and a mutation of the T20 residue N656/L that binds to this segment abrogates fusion Fluorescence intensity plate reader
Step Notes completely. 26, 27 This receptor target could be used to interrogate small molecule replacements of T20. It is also straightforward to modify the receptor for small molecule discovery to include common T20 resistance mutations.
CD Studies of Six-Helix Bundle Formation
A change in the CD signature for a mixture of receptor and Cpeptide compared to the sum of individual spectra reflected complex formation. Example CD spectra are shown in F2 Figure 2 for the peptide pairs Fe(env5.1) 3 /C39-e5.1, Fe(env5.1) 3 /C28-e5.1, and Fe(env6.0) 3 / C21-e6.0. An increase in helicity accompanied formation of the complex between cognate peptides Fe(env5.1) 3 /C39-e5.1 and Fe(env6.0) 3 /C21-e6.0, with the large negative molar residue ellipticity at both 222 and 208 nm indicative of six-helix bundle (6HB) formation. 21, 28, 29 Thus aggregation of Fe(env5.1) 3 did not preclude C-peptide binding. In Figure 2B , association of a truncated peptide C28-e5.1 with Fe(env5.1) 3 resulted in a distorted CD curve relative to that of the typical helix bundle. C28-e5.1 is missing the residues that bind in the HP, which is likely to lead to a combination of aggregation and an unstable six-helix structure. This effect has been observed in previous studies using T20 as the C-peptide. T4   Table 4 . The assay pair Fe(env3.0) 3 /C27-e3.0 (K D = 1.2 -0.2 mM) has been discussed elsewhere 14 and is not evaluated further here.
Inhibition constants were determined for unlabeled peptides, with the expectation that the observed K I for a peptide inhibitor should equal the K D of that peptide as a probe, barring any interference from a # is a model number that refers to a particular construct of the NHR coiled coil; C-peptides are labeled by the number of residues n and a matching env#. C-peptides are fluorophore labeled at a C-terminal cysteine. Amino acids forming key interactions at a and d positions of the heptad repeat are indicated in bold. B is aaminoisobutyric acid. T20 is included for reference, but is not an assay peptide. the fluorescent group. This was found to be the case with one exception (see below). K I 's are reported in T5 Table 5 . Fe(env5.1) 3 was not generally used as a receptor in inhibition experiments due to aggregation at the required concentrations. In the typical experiment, a probe and an inhibitor were premixed before adding a receptor, although in moderate affinity assays (K D * 1 mM), rapid equilibrium was also achieved by adding the inhibitor to the premixed receptor and probe. K D and K I data enabled us to determine the energetic contribution of various subsites to 6HB formation, stability, and inhibition. K D , or K I in self-inhibition, is expected to reflect both the enthalpic contribution to binding energy from the length and characteristics of the helix-helix interface and the entropic penalty associated with C-peptide helical content changes ( Table 3) .
14 K I in heterologous assays, on the other hand, could provide information about the contribution of a subsite in stabilizing the longer ectodomain.
The HP Plus About Five Residues Immediately Upstream was the Only Significant Hotspot Mediating the Helix-Helix Interaction C32-e5.0 had 50-fold increased affinity over C28-e5.1 for Fe(env5.0) 3 , highlighting the importance of the HP-binding region, in agreement with previous binding and mutagenesis studies. [31] [32] [33] C21-e6.0, directed to the region of the NHR that readily mutates upon exposure of the intact virus to T20, had 10-fold reduced affinity compared to C28-e5.1, indicating that important interactions with the NHR involved the segment 637 NYTSLI 642 (wild-type sequence, residues in bold interact in the NHR groove). Truncated T20 variants missing this segment demonstrated a dramatic loss of antiviral potency. 34 These residues were also essential for the 0.8 mM affinity of the HP-binding peptide C18-e2.0 (unpublished observation and reference 35 ), although they are not considered to be part of the pocket-binding domain. Inhibition data in heterologous assays confirmed the expanded HP interaction with C18-e2.0 as the most significant hotspot mediating 6HB formation. Thus, C18-e2.0 was able to inhibit the much longer Fe(env5.0) 3 -C32-e5.0FL interface at about the same K I as for selfinhibition, while peptides corresponding to other segments (C28-e5.1, Fig. 2 . Circular dichroism spectra for assay pairs using the long receptor Fe(env5.1) 3 (A, B) and the T20-binding site Fe(env6.0) 3 (C) The open triangles represents the sum of the C-peptide and Fe(env#) 3 spectra, the expected spectrum of the mixture if the peptides did not interact. All spectra were obtained at 20 mM peptide in a buffer at pH 7. Interactions Between NHR and CHR at the Base of the Coiled Coil were Energetically Significant, but Could not Inhibit 6HB Formation
The peptide pair Fe(env6.0) 3 and C21-e6.0 representing the base of the 6HB formed a complex with a 1 mM K D /K I , a reasonably strong association, involving both hydrophobic and polar interactions (Fig. 1) 3 . Differences in the effect of the mutation appeared to be due to compensatory interactions of C21-e6.0 with 540 QARQLL 545 .
The reduction of potency of C21-e6.0 in heterologous assays was particularly striking, since it was unable to displace either C32-e5.0FL or C28-e5.1FL/LY from Fe(env5.0) 3 at concentrations up to 200 mM. It displaced C28-e5.1FL/LY from Fe(env6.0) 3 with six-fold reduced K I compared to inhibition of self, and was unable to displace C21-e6.0FL. There is an overwhelming evidence from structural and mutagenesis studies that the NHR-CHR interaction spanned by Fe(env6.0) 3 -C21-e6.0 forms part of the 6HB core, and plays a critical role in gp41 function. 22, 27 Thus, while there is clear evidence for NHR-CHR stabilizing interactions in this region, our data and other studies 36 suggest they do not appear to play a central role in disrupting or preventing 6HB formation.
The Base of the Coiled Coil Showed Conformational Variability and Flexibility
Effects, including nonspecific hydrophobic interactions and deviations from 1:1 binding in constructs containing residues at the base of the coiled coil, were suggestive of conformational flexibility in this region. The segment 540 QARQLL 545 was implicated in nonspecific binding of the hydrophobic C-terminal FL group, which interfered in assays with Fe(env5.1) 3 or Fe(env6.0) 3 , resulting in an observed K D of FL-labeled peptides three-fold lower than the K D for the corresponding LY-labeled peptides ( Fig. 4A; Table 4 ) or the K I of unlabeled peptides ( Table 5) . No association with free FL was observed. It was further found that unlabeled C21-e6.0 could not displace C21-e6.0FL from Fe(env6.0) 3 , while readily displacing C21-e6.0LY (Fig.  4B) , or either the probe peptide from the receptor Fe(env5.0) 3 . Interestingly, FL-labeling resulted in a K D closer to the 100 nM K I observed for T20 binding to Fe(env6.0) 3 . T20 showed mid-nM inhibition in all Receptor peptides are named env followed by a version number, probe peptides are labeled Cn followed by a version number. Experiments were repeated in quadruplicate and on at least two different days for each assay pair. The standard deviation is shown. Shaded areas correspond to noncompatible pairs. assays except Fe(env2.0) 3 -C18FL, which was to be expected, since T20 does not contain HP-binding residues. The hydrophobic tail of T20 binds to the fusion-peptide proximal region, which is not included in env6.0. Therefore some nonspecific hydrophobic effect was occurring with T20 as well.
The nonspecific binding resulted in deviations from normal 1:1 binding with C21-e6.0FL and to a lesser extent C21-e6.0LY. Binding curves displayed sharp transitions with a Hill coefficient > 1.5 (e.g., Fig. 4A ). The fluorescent label appeared to be a principle factor in inducing the effect, since unambiguous 1:1 binding was observed in the inhibition data for C21-e6.0 (Fig. 4B) . The effect was observed only for the 21-residue peptide, where nonspecific interactions could likely contribute a significant proportion of the affinity. Some type of distortion is necessary to explain the fluorophore interaction, since it was designed to point away from the NHR-CHR interface in a purported six-helix structure. The observed cooperative binding transition may be associated with conformational variation from the expected six-helix structure. A recent crystal structure of full length ectodomain, including the membrane proximal external region (MPER), indicated that splaying and loss of the NHR helical structure occurred in this region. 22 It is possible that FL could partially mimic the MPER in inducing a structural change.
High-Affinity Small Molecule Binding was Specific to the HP and Suggested a Dependence of Potency on Off-Rate
Assay performance was evaluated for potency and specificity with several confirmed low to sub-mM HP-binding inhibitors. 18 Three of these, 6a, 14c, and 14g are listed in Table 5 , together with K I 's determined in all assays. They were selected because they have similar affinities in the HP-binding assay Fe(env2.0) 3 /C18-e2.0, but differ in their ability to impede fusion. 18 IC 50 's for fusion inhibition were 5, 8, and 0.8 mM, respectively, for 6a, 14c, and 14g. 14g (plus some similar unpublished derivatives) is the only verified sub-mM fusion inhibitor in this scaffold class and is also the only small molecule tested in our laboratory to efficiently block the extended Fe(env5.0) 3 -C32-e5.0FL helical interaction. To investigate whether this property could contribute to its improved biological activity, the assay suite was used to investigate the mechanism. 6a and 14c were weak or nonspecific inhibitors in all assays other than the HP-binding assay Fe(env2.0) 3 -C18-e2.0. The inhibition curves for 14g in F5 Figure 5A demonstrated low mM inhibition of the interactions Fe(env2.0) 3 -C18-e2.0, and Fe(env5.0) 3 -C32-e5.0. Minimal inhibition in the Fe(env6.0) 3 -C28-e5.1 assay implied that the molecule was located specifically within the confines of the HP. 15 Additional nonspecific inhibition occurred at the base of the coiled coil, as evidenced by a sharp rise in signal in assays with Fe(env6.0) 3 and C21-e6.0FL/LY at high inhibitor concentrations. However, unexpectedly, 14g inhibited C28-e5.1 and C21-e6.0 binding to Fe(env5.0) 3 , with an apparent 1:1 binding mechanism, contrary to the results obtained with Fe(env6.0) 3 . Further experimentation revealed that 14g did not inhibit C28-e5.1 or C21-e6.0 binding to Fe(env5.1) 3 (except nonspecifically at high concentrations). Rather, it increased the amount of bound C-peptide as evidenced by a reduction in baseline fluorescence upon addition of up to 25 mM 14g (Fig. 5B) . The increased availability of binding sites for the probe peptide is presumed due to reduction of aggregation of the receptor when 14g occluded the HP. At concentrations above 25 mM, the familiar nonspecific binding of 14g to the base of the 6HB occurred. For comparison, 1:1 binding of C21-e6.0 due to competitive inhibition of Fe(env5.1) 3 -C21-e6.0LY is shown in Figure 5B . The apparent inhibition by 14g of C28-e5.1LY and C21-e6.0LY binding to Fe(env5.0) 3 appeared to be spurious in that it did not represent competitive inhibition of the NHR-CHR interaction. The only difference between this receptor and Fe(env5.1) 3 is the presence in the latter of the additional segment 540 QARQLL 545 , which has been associated with nonspecific binding of both fluorescently labeled Cpeptide and 14g. Indeed, nonspecific binding of 14g to Fe(env5.0) 3 was not observed. It is likely that Fe(env5.0) 3 is not an ideal assay partner for C21-e6.0FL/LY and C28-e5.1FL/LY, despite quenching (14) 139 (24) 184 (24) 14c ( the fluorescence of these peptides upon binding. It appeared that the C-terminal heptad overhang of the probe peptides, and the metal binding group of the receptor (Fig. 1 ) generated a non-natural site for 14g binding.
Having ruled out multiple-site binding for 14g as a mechanism for its increased potency in the high-affinity assay Fe(env5.0) 3 -C32-e5.0FL and in fusion inhibition, off-rate was examined as a possible contributor to potency. Off-rate can be slowed by a protein conformational change associated with ligand binding. 37 Order of addition assays were used to obtain a rough estimate of the on and off-rates for C32-e5.0 with the receptor Fe(env5.0) 3 
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Supplementary Fig. S1 ; Supplementary Data are available online at www.liebertpub.com/adt). The slow kinetics permitted us to evaluate the effect of a small molecule ligand bound to Fe(env5.0) 3 by premixing the receptor with a low concentration of the ligand, and observing the time to equilibrium after adding C32-e5.0FL. This experiment is shown in Figure 5C for the ligands 3a, 14c, and 14g, and suggested three to five times slower off-rate for 14g than for 3a and 14c (see also Supplementary Fig. S1 ). Thus, the increased potency of 14g over earlier derivatives 3a and 14c could be attributed to differences in binding kinetics.
CONCLUSIONS
This study demonstrated a suite of assays for probing binding and segmental activity of the coiled coil domain of HIV-1 gp41. The assays encompass HP or T20 subsite detection, as well as full-length 6HB coverage. Dissociation and inhibition constants for peptides and small molecules accurately reflected both affinity and specificity provided the CHR probe peptide had a complete cognate-binding site on the Fe(env#) 3 receptor. The assay Fe(env6.0) 3 /C21-e6.0LY, simulating the T20-binding site where resistance mutations are common, is the newest addition to our repertoire for examining gp41. The 1 mM K D indicates that it can be used to detect inhibitors in the low mM to mM range that have a unique binding site apart from the HP. Experiments here demonstrate that use of the probe peptide in its LYlabeled form will be preferential over FL-labeling.
Importantly, many of the biophysical results that were obtained matched very well with observed biological data. The assays revealed that the HP was the sole hotspot mediating the NHR-CHR interaction, conferring significant stability to the 6HB. The first five residues of T20, which are critical for antiviral activity, were also necessary for high-affinity binding to the coiled coil. Peptides containing a known inactivating mutation N656L displayed a dramatic loss of potency. Evidence for a break in the rigid helical structure toward the base of the coiled coil was obtained, both from the inability of a C-peptide from this region to disrupt 6HB formation and from indication of conformational flexibility upon probe binding. The assay representing the 6HB segment at the base of the coiled coil showed unique features compared to the other assays, including interference of the FL group in binding, resulting in a cooperative binding transition, inability of the unlabeled peptide to compete with its FL-labeled counterpart, and nonspecific binding of hydrophobic compounds. The overall agreement between known biological properties and observed binding properties of the C-peptides confirmed the Results from dimethyl sulfoxide only controls have been subtracted from the data. Early data points ( < 2,000 s) are omitted due to artifacts of physical mixing. Color images available online at www.liebertpub.com/adt accuracy of the metallopeptide receptor models in representing the intact gp41 NHR trimer.
Evaluation of a sub-mM small molecule fusion inhibitor revealed that it was able to effectively inhibit the high-affinity interaction between a 40-residue NHR construct and a 32-residue CHR peptide. Small molecules that were not able to inhibit this interaction in the low to sub-mM range were found to have ‡10-fold weaker activity against cell-cell fusion, even if they had similar ability to disrupt an 18-residue CHR peptide binding in the HP. This property is demonstrated here with just three inhibitors, but recent results (unpublished) have indicated that it applies more broadly and may be a unique identifying property of effective low molecular weight fusion inhibitors. The mechanism of extended NHR-CHR inhibition appears to be associated with lower off-rate of the small molecule ligand, with binding specificity restricted to the HP. The assay suite could be used to aid in the discovery of alternative ligands, which bind adjacent to the pocket and, which could be tethered to HP-binding inhibitors, leading to a significant increase in potency.
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SUPPLEMENTARY DATA NUMERICAL ESTIMATE OF k on AND k off
The time course of fluorescence of a ternary system containing receptor R, probe P, and inhibitor I was evaluated using equilibrium and mass balance equations for standard 1:1 binding R + P Ð The differential equations were programmed into Mathcad ( Mathsoft). Initial conditions and total concentrations of components were set according to the experimental setup (see caption to Supplementary Fig. S1 ). Dissociation and inhibition constants K D and K I were taken from Tables 4 and 5 . The solution to the differential equations was obtained using the Rkadapt function, returning species concentrations from which F obs (t) was calculated. The kinetic parameters k 1off and k 2off were varied to obtain a best fit to the data shown in Supplementary  Figure S1 .
The slow on-rate for 14c and 14g may be due to slow mixing of the DMSO, and may be an artifact of the assays given that up to 30 min was required to reach equilibrium of DMSO-only solutions after manual mixing in the 384-well plates. Relative rates between different compounds dissolved in DMSO can be compared, but absolute rates are not definitive AU6 . Supplementary Fig. S1 . Order of addition assays with Fe(env5.0) 3 -C32-e5.0FL. P, R, and I are C32-e5.0FL, Fe(env5.0) 3 , and indicated inhibitor, respectively. 14c and 14g were added as dimethyl sulfoxide (DMSO) solutions. Fluorescence was measured over time as a function of the order in which components were mixed in the assay. The symbol after the plus sign indicates the component that was added last. Experiments were conducted in a 384-well plate after manual mixing and the fluorescence followed over 2 h. Also shown are responses when the inhibitor was omitted from the DMSO solution. Data were fit numerically to standard 1:1 binding and mass balance equations using Mathcad (Mathsoft). The kinetic parameters obtained for the curves shown in the figure are as follows: 
